These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


412 related items for PubMed ID: 4936984

  • 1. Use of allogenic, homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum.
    Gozzo JJ, Wood ML, Monaco AP.
    Surg Forum; 1970; 21():281-4. PubMed ID: 4936984
    [No Abstract] [Full Text] [Related]

  • 2. Bone marrow origin of nonsensitized effector cells in skin allograft rejection.
    Kongshavn PA, Lapp WS.
    Transplantation; 1973 Oct; 16(4):382-4. PubMed ID: 4583154
    [No Abstract] [Full Text] [Related]

  • 3. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
    Gozzo JJ, Wood ML, Pompei R, Monaco AP.
    Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sex difference in specific and non-specific suppression of non-H-2 allograft responsiveness in mice.
    Nĕmec M.
    Folia Biol (Praha); 1971 Mar; 17(4):220-6. PubMed ID: 4943668
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J, Fries D.
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Immunological and hematological effects of anti-thymocyte serum and anti-bone marrow cell serum].
    Yokoro K, Imamura N.
    Saishin Igaku; 1971 Aug 10; 26(8):1502-12. PubMed ID: 5570224
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of antilymphocyte serum and bone marrow for production of immunological tolerance and enhancement: review and recent experiments.
    Wood ML, Gozzo JJ, Monaco AP.
    Transplant Proc; 1972 Dec 10; 4(4):523-9. PubMed ID: 4405146
    [No Abstract] [Full Text] [Related]

  • 16. The effects of phytohemagglutinin and antilymphocyte globulin in inducing immunosuppression and tolerance in mice.
    Moore CD, Slavin RG.
    Transplantation; 1971 Jun 10; 11(6):563-6. PubMed ID: 4931456
    [No Abstract] [Full Text] [Related]

  • 17. The cytologic bases of immune responses.
    Turk JL.
    Adv Biol Skin; 1971 Jun 10; 11():45-61. PubMed ID: 4950055
    [No Abstract] [Full Text] [Related]

  • 18. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E, Bennett M.
    Immunology; 1971 Jul 10; 21(1):123-36. PubMed ID: 4934136
    [Abstract] [Full Text] [Related]

  • 19. Cells involved in the immune response. XXVII. The demonstration of appendix-specific antigens in the rabbit.
    Colas de la Noue H, Richter M.
    Immunology; 1974 Sep 10; 27(3):421-6. PubMed ID: 4137568
    [Abstract] [Full Text] [Related]

  • 20. Tissue distribution of I region-associated antigens in the mouse.
    Hauptfeld V, Hauptfeld M, Klein J.
    J Immunol; 1974 Jul 10; 113(1):181-8. PubMed ID: 4598886
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.